CNS Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $2.5M | $8.7M | $6.5M |
| FY2025 | $4.1M | $8.6M | $7.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $2.5M | $8.7M | $6.5M |
| FY2025 | $4.1M | $8.6M | $7.2M |